Novel versus Conventional sequencing of Beta-blockers, SGLT2i’s, ARNI’s and MRAs in stable patients with HFrEF (NovCon sequencing study): Protocol for a 5-year pragmatic, real world, single-blinded, randomised controlled trial (Preprint)

Novel versus Conventional sequencing of Beta-blockers, SGLT2i’s, ARNI’s and MRAs in stable patients with HFrEF (NovCon sequencing study): Protocol for a 5-year pragmatic, real world, single-blinded, randomised controlled trial (Preprint)

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JMIR research protocols 2022-11
Hauptverfasser: Karamchand, Sumanth, Chipamaunga, Tsungai, Naidoo, Poobalan, Naidoo, Kiolan, Rambiritch, Virendra, Ho, Kevin, Chilton, Robert, McMahon, Kyle, Leisegang, Rory, Weich, Hellmuth, Hassan, Karim
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:1929-0748
1929-0748
DOI:10.2196/44027